KMT2D is considered a tumor suppressor gene, and its mutations are associated with non-Hodgkin lymphoma, including diffuse large B-cell (DLBCL) and follicular lymphoma, as well as some solid tumors such as small cell lung cancer (22, 23). Here, KMT2D is linked to diffuse large B-cell lymphoma.